How to legally get Mounjaro online in California

In the rapidly evolving landscape of weight management, GLP-1 medications like Wegovy, Ozempic, and Mounjaro have emerged as game-changers. With rising demand comes a pressing question: can you legally access these medications through telehealth services, without visiting a doctor’s office? The short answer is yes—but with important nuances depending on where you live.

This comprehensive guide breaks down the current telehealth landscape for GLP-1 weight loss medications in 2025, helping you understand how to safely and legally access these treatments online.

The Legal Status of Telehealth GLP-1 Prescriptions: The Basics

First, some good news: GLP-1 medications for weight loss are NOT controlled substances under federal law. This makes them fundamentally different from medications like Adderall or phentermine, which have strict prescribing limitations.

Since Wegovy, Ozempic, and similar GLP-1 agonists aren’t controlled substances, they’re exempt from the Ryan Haight Act’s in-person examination requirement at the federal level. This means that in most states, a qualified healthcare provider can legally prescribe these medications via telehealth after a proper virtual evaluation.

However, state regulations create a patchwork of rules that affect how these medications can be prescribed online.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Rules for Weight Loss Medications

While telehealth prescribing for GLP-1s is widely permitted, some states have imposed additional requirements. Here’s what you need to know about key states:

States with NO In-Person Requirements

These states allow full telehealth prescribing with no mandatory in-person visits:

• California: Telehealth explicitly permitted with no in-person requirements
• Connecticut: Virtual consultations sufficient for prescribing
• Florida: No in-person exam required (though follow-ups every 3 months are mandated)
• Illinois: Complete telehealth approach permitted
• New York: Fully embraces telehealth prescribing
• Washington: Pioneer in telehealth with no in-person requirements

States Requiring an Initial In-Person Visit

These states mandate an in-person evaluation at some point, usually before starting treatment:

• Arkansas: Initial in-person examination required
• Delaware: Must have an initial physical examination
• Georgia: In-person exam required prior to telehealth prescribing
• Mississippi: Requires seeing the patient in-person at least once
• New Jersey: Comprehensive in-person exam and labs required initially
• North Dakota: In-person initial evaluation expected
• South Carolina: Must examine patient in person first
• Texas: Initial in-person exam generally expected
• Utah: Initial in-person exam encouraged
• Virginia: Must perform physical exam and labs initially

It’s worth noting that even in states with an initial in-person requirement, follow-up appointments and ongoing management can typically be handled via telehealth.

Who Can Prescribe GLP-1 Medications via Telehealth?

The qualifications of your telehealth provider matter, and regulations vary by state:

• Physicians (MDs/DOs): Can prescribe GLP-1 medications via telehealth in all states (if licensed in the patient’s state)

• Nurse Practitioners (NPs):

• Full independent prescribing authority in states like California, Connecticut, New York, North Dakota, Utah, Virginia, and Washington

• Require physician collaboration or supervision in states like Arkansas, Florida, Georgia, Illinois, Mississippi, New Jersey, Pennsylvania, South Carolina, and Texas

• Physician Assistants (PAs):

• Generally require some level of physician supervision in most states

• Specific restrictions vary by state

At Klarity Health, we ensure all providers are appropriately licensed and qualified according to the regulations of your state, giving you peace of mind that your telehealth care meets all legal requirements.

What to Expect During a Legitimate Telehealth Evaluation

Reputable telehealth providers follow a structured process for GLP-1 prescribing that includes:

1. Comprehensive health evaluation: A detailed review of your medical history, current medications, allergies, and weight management history

2. BMI assessment: Verification that you meet clinical criteria (typically BMI ≥30, or BMI ≥27 with weight-related conditions)

3. Risk screening: Identification of potential contraindications such as pregnancy, history of medullary thyroid carcinoma, pancreatic issues, or severe GI disorders

4. Lifestyle discussion: Development of a plan that incorporates diet and exercise alongside medication

5. Informed consent: Clear explanation of potential side effects, expected outcomes, and alternatives

6. Follow-up schedule: Regular check-ins to monitor progress, typically starting 1 month after beginning treatment

Klarity Health provides all these elements through our user-friendly platform, connecting you with qualified providers who can assess your needs and, if appropriate, prescribe GLP-1 medications according to your state’s regulations.

Red Flags: How to Avoid Illegitimate Telehealth Services

As GLP-1 medications have gained popularity, some questionable operators have emerged. Be wary of any telehealth service that:

• Guarantees you’ll receive a prescription without a thorough evaluation
• Offers ‘compounded’ versions of semaglutide (FDA banned most compounded versions in 2025)
• Doesn’t require detailed medical information or a live consultation
• Skips discussion of side effects, risks, and alternatives
• Lacks transparency about provider credentials or state licensing
• Doesn’t plan for regular follow-up appointments

Telehealth Advantages for Weight Management

For many patients, telehealth offers significant advantages for obesity treatment:

• Accessibility: Removes transportation barriers and allows treatment from home
• Reduced stigma: Some patients feel more comfortable discussing weight concerns virtually
• Convenience: Appointments fit more easily into busy schedules
• Continuity: Regular check-ins are easier to maintain
• Privacy: Consultations happen in your own space

At Klarity Health, we’ve designed our platform to maximize these benefits while maintaining the highest standards of medical care. Our providers take the time to understand your health history, discuss treatment options thoroughly, and develop personalized plans for sustainable weight management.

Insurance Coverage and Costs

Many insurance plans now cover telehealth consultations, though coverage for GLP-1 medications varies significantly:

• Some commercial plans cover these medications with prior authorization
• Medicare Part D may cover them for diabetes but typically not for weight loss
• Many plans require documentation of BMI and previous weight loss attempts

Klarity Health works with many insurance providers and also offers transparent pricing for those paying out-of-pocket. We can help you understand your options and potential costs before beginning treatment.

Looking Ahead: The Future of Telehealth for GLP-1 Medications

The regulatory landscape continues to evolve, but several trends are clear:

• Telehealth access for non-controlled medications like GLP-1s is likely to remain stable
• More states are moving toward flexible telehealth policies
• Regulators are focusing on maintaining appropriate standards of care rather than limiting access
• Interstate licensure compacts are making cross-state telehealth easier

As these changes occur, Klarity Health remains committed to providing compliant, high-quality telehealth care for weight management while navigating the evolving regulatory environment.

Conclusion: Is Telehealth Right for Your Weight Management Journey?

GLP-1 medications represent a powerful tool in the fight against obesity, and telehealth has made these treatments more accessible than ever before. For most patients in most states, it’s entirely possible to obtain Wegovy, Ozempic, or similar medications through legitimate telehealth services, following appropriate evaluation and ongoing care.

If you’re considering a GLP-1 medication for weight management, Klarity Health can connect you with licensed providers who understand both the clinical aspects of these medications and the specific regulations in your state. Our providers take the time to perform thorough evaluations, discuss potential benefits and risks, and develop personalized treatment plans that comply with all applicable laws.

Ready to explore whether GLP-1 medication might be right for you? Schedule a virtual consultation with Klarity Health today to discuss your options with a qualified healthcare provider.

📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 17, 2025

Sources:

1. DEA.gov – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ (November 15, 2024)
2. Axios News – ‘COVID-era telehealth prescribing extended’ (November 18, 2024)
3. McDermott Law – ‘Insight on DEA Telemedicine rules’ (November 18, 2

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid